August 19, 2019
The Trump administration is working to permit the importation of less-expensive prescription drugs originally intended for foreign markets.
July 11, 2019
As the 2020 election creeps closer, candidates are focusing increasingly more on solving one of the most vexing problems Americans regularly encounter: the incredibly high cost of prescription drugs.
March 7, 2019
ALSO: 95% of Voters Believe Patients and Doctors, not Bureaucrats, Should Be Most Responsible for Treatment Decisions
May 22, 2018
"Now, at long last, American patients and their families can have hope that a life-saving drug will no longer be denied to them because of bureaucratic barriers." -- Dr. Tim Huelskamp
May 18, 2017
In a letter signed by The Heartland Institute, the authors argue drug importation would ultimately harm patients.
March 1, 2005
Anyone who watches television or reads popular magazines knows the amount of money spent on advertising for prescription drugs has increased dramatically in the past few years.
February 1, 2005
An end-of-year Associated Press poll showed that, despite recent product withdrawals and reported health risks of popular medicines, U.S. consumer confidence in the safety of prescription drugs remains high.
April 1, 2002
State elected officials across the country, hard-pressed to keep expensive promises they made during the good economic times of the 1990s, are considering legislation that would force drug manufacturers to pay “supplemental rebates”to have their drugs
August 1, 2007
The following is an excerpt from the booklet More Choices, Better Health: Free to Choose Experimental Drugs, by Bartley J. Madden--the third in a several-part series. The complete booklet is also available online at http://www.heartland.org/Article.cfm?
December 5, 2006
(Chicago, Illinois - December 5, 2006) The U.S. Government Accountability Office is expected to release a study on direct-to-consumer advertising (DTC) of prescription drugs in the coming weeks.
December 1, 2004
Ten years ago, the multinational pharmaceutical company AstraZeneca launched what was known inside the company as the Shark Fin Project.
September 1, 2004
In July, the U.S. House and Senate passed and sent to the president the U.S.-Australia Free Trade Agreement.
April 13, 2020
The so-call "Purple Book" is a list of all licensed biologic products and is a reference guide for patients, providers, payers and manufactureres.
April 2, 2020
America is completely dependent on China and India for its pharmaceutical drug supply.
December 17, 2019
The U.S. Senate considers the nomination of Stephen Hahn to head the FDA.
December 5, 2019
Parmacogenetic testing is a new field in prescription medicine.
May 28, 2019
The biosimilar drug industry, along with consumer, taxpayer and health care groups are crying foul over the Food and Drug Administration’s newly released guidelines requiring a four-letter suffix on biosimilar drug names that would distinguish them from t
November 20, 2018
The U.S. Food and Drug Administration (FDA) approved a record number of generic drugs in fiscal year 2018.
May 2, 2019
Seven groups express concern over FDA's newly released guidelines onbio similar naming
July 26, 2017
The federal agency has published the list to enhance competition.
December 9, 2018
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb issued guidance to streamline the development of generic versions of complex drugs delivered by transdermal and topical delivery systems (TDS).
May 16, 2018
According to its mission statement, the Food and Drug Administration (FDA) is responsible for “advancing public health” by providing oversight to the drug development process.
May 29, 2019
Florida has joined Colorado, Missouri, Utah, Vermont, and West Virginia in attempting to save money on prescription drugs by importing them from another country.
March 6, 2019
93% of Voters Want FDA Reform to Allow Faster Approval of Prescription Drugs
March 23, 2015
In a move that could lower prescription drug costs for some of the most expensive treatments on the market, the U.S. Food and Drug Administration (FDA) approved for the first time a “biosimilar” for sale in the United States.
June 1, 2018
The Trump administration has recently released a plan to target the price of prescription drugs by implementing free-market solutions to help bring down the cost of health care.
July 14, 2011
Internal disagreements among staffers at the U.S. Food and Drug Administration could be contributing to slowdowns in prescription drug approval and delays in reaching goals under the Prescription Drug User Fee Act, a new report finds.
March 16, 2017
Four former FDA commissioners wrote an open letter asking President Donald Trump to resist a policy of importing drugs from foreign countries.
March 9, 2018
A large majority of registered voters say Congress should prioritize reducing prescription drug prices, according to a poll commissioned by an independent national patient organization.
April 10, 2017
Importing drugs from foreign countries would import price controls from foreign governments and result in unsafe and ineffective treatments, experts say.
July 1, 2007
Congress is one step closer to passing legislation that would give the Food and Drug Administration (FDA) more authority in handling approval and monitoring of prescription drugs.
December 26, 2016
An insurer declines to cover a drug the FDA granted accelerated approval.
September 21, 2017
Free To Choose Medicine legislation has the potential to gather bipartisan support as a practical means to accelerate innovation and lower the costs of prescription drugs.
October 1, 2004
Illinois plans to become the first state to directly help residents buy prescription drugs from Europe. The state plans to launch a Web site for residents to buy name-brand drugs from Ireland, the United Kingdom, and Canada.
April 1, 2004
A strongly worded letter from the U.S. Food and Drug Administration (FDA) warned Minnesota Governor Tim Pawlenty (D) that his decision to establish a Web site offering prescription drugs from Canadian pharmacies is “unsafe, unsound and ill-considered.
January 21, 2015
Colorado Rep. Diana DeGette (D) is urging the Food and Drug Administration (FDA) to recognize the importance of Internet communication in drug research.
November 2, 2011
The American medical community consistently creates new drugs and procedures to advance health care. Unfortunately, those advancements face heavy resistance from the Food and Drug Administration (FDA) and often are not accessible to many patients in need.
November 21, 2003
November 6, 2003
Special Advocates for Prescription Drugs
100 W. Randolph Street, Floor 4, Suite 457
Chicago, Illinois 60601
Dear Dr. Kamath and Mr.
March 23, 2011
In recent years, the Food and Drug Administration (FDA) has struggled with an increasing number of disagreements among its scientific staff. Many of these disputes have spilled out into public view.